• Users Online: 186
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

Traditional chinese medicine in ameliorating diabetic kidney disease via modulating gut microbiota

Yang Yanan, Wu Chongming

Year : 2021| Volume: 8| Issue : 1 | Page no: 8-8

   This article has been cited by
 
1 Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice
Gang Cao, Hua Miao, Yan-ni Wang, Dan-qian Chen, Xia-qing Wu, Lin Chen, Yan Guo, Liang Zou, Nosratola D. Vaziri, Ping Li, Ying-yong Zhao
Acta Pharmacologica Sinica. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Glycyrrhiza uralensis root extract ameliorates high glucose-induced renal proximal tubular fibrosis by attenuating tubular epithelial-myofibroblast transdifferentiation by targeting TGF-1/Smad/Stat3 pathway
Henry Cherng-Han Lin, Catherine Reena Paul, Chia-Hua Kuo, Yung-Hsien Chang, William Shao-Tsu Chen, Tsung-Jung Ho, Cecilia-Hsuan Day, Bharath Kumar Velmurugan, Yuhsin Tsai, Chih-Yang Huang
Journal of Food Biochemistry. 2022; 46(5)
[Pubmed]  [Google Scholar] [DOI]
3 Tilianin Reduces Apoptosis via the ERK/EGR1/BCL2L1 Pathway in Ischemia/Reperfusion-Induced Acute Kidney Injury Mice
Zengying Liu, Chen Guan, Chenyu Li, Ningxin Zhang, Chengyu Yang, Lingyu Xu, Bin Zhou, Long Zhao, Hong Luan, Xiaofei Man, Yan Xu
Frontiers in Pharmacology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
4 Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
Yan-Ni Wang, Hao-Yu Feng, Xin Nie, Ya-Mei Zhang, Liang Zou, Xia Li, Xiao-Yong Yu, Ying-Yong Zhao
Frontiers in Pharmacology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
5 Recent advances of gut microbiota in chronic kidney disease patients
Ying-Yong Zhao
Exploration of Medicine. 2022; : 260
[Pubmed]  [Google Scholar] [DOI]

 

Read this article